Product Images Carvedilol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Carvedilol NDC 68071-4980 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PDP - 68071 4980 6
NuCare Pharmaceuticals, Inc. is the manufacturer of Carvedilol 3.125mg tablets. Each bottle contains 60 tablets and the lot number is 000000, with an expiry date of 00-00. The tablets are circular and white with an engraving of 'G' on one side. Carvedilol is useful to manage high blood pressure and to treat heart failure. However, it may cause side effects, and in that case, one must consult a doctor or contact FDA at 1-800-FDA-1088. The pill bottle must be stored in temperatures of 68-77°F and must be kept inaccessible to children.*
figure-1 - figure 1
This appears to be a graph of some sort displaying the results of a study or experiment. The graph shows the effectiveness of a medication or treatment (Carvedilol) compared to a placebo over a period of time (30-, 3, 6, 9, 12, 15, 18, and 21). The results indicate that the medication was significantly more effective than the placebo (P=0.0014). No further information is available on the study or experiment.*
figure-2 - figure 2
figure-3 - figure 3
The text corresponds to a graph showing the survival analysis for CAPRICORN. The x-axis shows a timeline ranging from 0 to 24, and the y-axis represents the number of patients. The plot shows the survival rate of patients treated with Carvedilol and Placebo. The survival rate of Carvedilol treated patients is significantly higher, with a P-value of 0.03. The significance indicates that the difference in the survival rate of Placebo and Carvedilol groups is statistically significant.*
figure-4 - figure 4
This appears to be a table or data visual from a clinical study, showing the effects on mortality for subgroups in CAPRICORN. There are several subgroups listed such as age, gender, use of diuretics, hypertension, and diabetes, with corresponding hazard ratios displayed for each subgroup. More information is needed on the study methodology and context to fully understand the significance of the data presented.*
carvedilol-chemical-structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.